Back
Vistagen Therapeutics, Inc. Stock Price Chart
Missed $0.81? RAD Intel Now Open at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
41
VTGN
Vistagen Therapeutics, Inc.
Last Price:
$4.28
Seasonality Move:
20.93%
7 Day Trial
ALL ACCESS PASS
$
7
Still Time to Get In: RAD Intel at $0.85/Share
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VTGN is experiencing buying pressure, which is a positive indicator for future bullish movement.
Vistagen Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.4 | Sell |
| 20-day SMA: | 4.25 | Sell |
| 50-day SMA: | 4.05 | Sell |
| 200-day SMA: | 2.98 | Buy |
| 8-day EMA: | 4.14 | Sell |
| 20-day EMA: | 3.44 | Buy |
| 50-day EMA: | 2.04 | Buy |
| 200-day EMA: | 0.64 | Buy |
Vistagen Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.93 | Buy |
| Relative Strength Index (14 RSI): | 41.71 | Sell |
| Chaikin Money Flow: | 864465 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.85 - 4.55) | Sell |
| Bollinger Bands (100): | (2.96 - 4.16) | Buy |
Vistagen Therapeutics, Inc. Technical Analysis
| Nov 19 | Nov 20 | Nov 21 | Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 19 | 20 | 21 | 24 | 25 | 26 | 28 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Vistagen Therapeutics, Inc. Stock
Is Vistagen Therapeutics, Inc. Stock a Buy?
-
Vistagen Therapeutics, Inc. share price is 3.73 while VTGN 8-day simple moving average is 4.40, which is a Sell signal.
-
The stock price of VTGN is 3.73 while Vistagen Therapeutics, Inc. 20-day SMA is 4.25, which makes it a Sell.
-
Vistagen Therapeutics, Inc. 50-day simple moving average is 4.05 while VTGN share price is 3.73, making it a Sell technically.
-
VTGN stock price is 3.73 and Vistagen Therapeutics, Inc. 200-day simple moving average is 2.98, creating a Buy signal.
VTGN Technical Analysis vs Fundamental Analysis
Sell
41
Vistagen Therapeutics, Inc. (VTGN)
is a Sell
Is Vistagen Therapeutics, Inc. a Buy or a Sell?
-
Vistagen Therapeutics, Inc. stock is rated a SellThe current Vistagen Therapeutics, Inc. [VTGN] share price is $3.73. The Score for VTGN is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
Vistagen Therapeutics, Inc. Stock Info
Market Cap:
147.3M
Price in USD:
3.73
Share Volume:
1.4M
Vistagen Therapeutics, Inc. 52-Week Range
52-Week High:
5.14
52-Week Low:
1.90
Sell
41
Vistagen Therapeutics, Inc. (VTGN)
is a Sell
Vistagen Therapeutics, Inc. Share Price Forecast
-
What is the Vistagen Therapeutics, Inc. stock price today?The Vistagen Therapeutics, Inc. stock price is 3.73 USD today.
-
Will VTGN stock go up or go down?Vistagen Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Vistagen Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Vistagen Therapeutics, Inc. is overvalued.
Is Vistagen Therapeutics, Inc. Stock a Buy?
-
Vistagen Therapeutics, Inc. share price is 3.73 while VTGN 8-day exponential moving average is 4.14, which is a Sell signal.
-
The stock price of VTGN is 3.73 while Vistagen Therapeutics, Inc. 20-day EMA is 3.44, which makes it a Buy.
-
Vistagen Therapeutics, Inc. 50-day exponential moving average is 2.04 while VTGN share price is 3.73, making it a Buy technically.
-
VTGN stock price is 3.73 and Vistagen Therapeutics, Inc. 200-day simple moving average is 0.64, creating a Buy signal.
Fundamental Analysis of Vistagen Therapeutics, Inc.
Is Vistagen Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.03 per share.
Technical Analysis of Vistagen Therapeutics, Inc.
Should I short Vistagen Therapeutics, Inc. stock?
-
VTGN Moving Average Covergence Divergence (MACD) indicator is 0.93, suggesting Vistagen Therapeutics, Inc. is a Buy
-
Vistagen Therapeutics, Inc. Relative Strength Index (RSI) is 41.71, which suggest Vistagen Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Vistagen Therapeutics, Inc. is (3.85 - 4.55), which suggest Vistagen Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Vistagen Therapeutics, Inc. is (2.96 - 4.16), which suggest Vistagen Therapeutics, Inc. is a Buy
* Vistagen Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.